Skip to main content
. 2018 May 2;3:51. [Version 1] doi: 10.12688/wellcomeopenres.14392.1

Figure 21. Src signature scores and dasatinib sensitivity.

Figure 21.

A comparison of Src signature scores calculated from triple-negative breast cancer cell lines ( Lawrence et al., 2015) and dasatinib sensitivity from the CCLE database ( Seashore-Ludlow et al., 2015).